Beat the Market the Zacks Way: Contineum Therapeutics, Suzano, PepsiCo in Focus [Yahoo! Finance]
Contineum Therapeutics, Inc. - Common stock (CTNM)
Company Research
Source: Yahoo! Finance
earnings largely neutralized by slower growth expectations, rising inflation concerns and geopolitical tension. The three major indexes, like the Nasdaq Composite, the S&P 500 and the Dow Jones Industrial Average, managed to stay afloat by 0.18%, 0.60% and 0.35%, respectively. Investors are concerned over uncertainty caused by the tariffs imposed by President Donald Trump, and rising geopolitical tensions between the United States and Iran. The Labor Department's Bureau of Labor Statistics reported that the Producer Price Index (PPI), which measures wholesale inflation, rose 0.5% for the month of January, after advancing by a downwardly revised 0.4% in December, exceeding the 0.3% consensus estimate. Core PPI climbed 0.8% after gaining 0.6% in December. These higher-than-expected numbers suggest that inflation may not be cooling as quickly as hoped. Weekly jobless claims remained low at 212,000, showing that the labor market is still relatively strong. Overall, the U.S. economy re
Show less
Read more
Impact Snapshot
Event Time:
CTNM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CTNM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CTNM alerts
High impacting Contineum Therapeutics, Inc. - Common stock news events
Weekly update
A roundup of the hottest topics
CTNM
News
- Contineum Therapeutics (CTNM) had its price target raised by Robert W. Baird from $14.00 to $20.00. They now have an "outperform" rating on the stock.MarketBeat
- Contineum Therapeutics Reports Fourth-Quarter 2025 Financial Results; Affirms Key Clinical Development Milestones [Yahoo! Finance]Yahoo! Finance
- Contineum Therapeutics Reports Fourth-Quarter 2025 Financial Results; Affirms Key Clinical Development MilestonesBusiness Wire
- Contineum Therapeutics to Present at the 2026 Leerink Partners Global Healthcare ConferenceBusiness Wire
- Contineum Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)Business Wire
CTNM
Earnings
- 3/5/26 - Beat
CTNM
Sec Filings
- 3/5/26 - Form S-8
- 3/5/26 - Form 424B5
- 3/5/26 - Form 10-K
- CTNM's page on the SEC website